IP Library Granted Patent US 7,241,868
Granted Patent B1
US 7,241,868 · App. 10/960,642 · Granted Jul 10, 2007

Crystallization of Glucocorticoid Receptor

Assignee: Takeda San Diego, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,241,868
App. No.
10/960,642
Granted
Jul 10, 2007
Kind
B1
Abstract

Provided are crystals relating to human Glucocorticoid Receptor and its various uses.

Claims (11)

1. A composition comprising a protein in crystalline form wherein the protein consists of SEQ ID NO:3, wherein said proteins forms a complex with a steroid ligand, and wherein the protein crystal has a crystal lattice in a P2 1 2 1 2 space group and unit cell dimensions, +/−5%, of a=202.02 Å, b=110.31 Å and c=116.62 Å, α=β=γ=90.

2. A composition according to claim 1 wherein the crystal diffracts X-rays for a determination of structure coordinates to a resolution of a value equal to or less than 3.0 Angstroms.

3. A method for forming a crystal of a protein comprising:

forming a crystallization volume comprising: a precipitant solution and a protein that consists of SEQ ID NO:3, wherein said proteins forms a complex with a steroid ligand, and wherein the protein crystal has a crystal lattice in a P2 1 2 1 2 space group and unit cell dimensions, +/−5%, of a=202.02 Å, b=110.31 Åand c=116.62 Å, α=β=γ=90, and

storing the crystallization volume under conditions suitable for crystal formation of the protein.

4. A method according to claim 3 wherein the crystal diffracts X-rays for a determination of structure coordinates to a resolution of a value equal to or less than 3.0 Angstroms.

5. A method according to claim 3 , the method further comprising diffracting the protein crystal to produce a diffraction pattern.

6. An isolated soluble protein consisting of residues 528-777 of SEQ ID NO:1.

7. The protein according to claim 6 wherein the protein is expressed from a nucleic acid molecule that consists of SEQ ID NO:2.

8. A soluble protein consisting of SEQ ID NO:3.

9. An isolated non-crystalline protein consisting of amino acids 528-777 of SEQ ID NO:1.

Assignments (2)
CHANGE OF NAME Recorded Aug 16, 2006
From: SYRX, INC.
To: TAKEDA SAN DIEGO, INC.
Reel/Frame 018132/0496 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2005
From: BROOUN, ALEXEI; BRODSKY, OLEG; CHIEN, ELLEN; DOUGAN, DOUGLAS R.; MOL, CLIFFORD D.; SNELL, GYORGY
To: SYRRX, INC.
Reel/Frame 016315/0748 →